ATM and cancer: Evidence also indicates that the main risk factor with regard to mortality is the possibility of respiratory tract infections in patients with hypomorphic mutations in ATM, although those with null mutations in “class A” disease have an increased risk of cancer at a younger age (Rothblum-Oviatt et al. 2016; Bhatt et al. 2015).